Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
764 USD | -1.65% | +5.61% | +31.33% |
02:24pm | Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1 | RE |
07:42am | Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.33% | 699B | |
+25.07% | 571B | |
-4.22% | 364B | |
+18.53% | 326B | |
+3.25% | 286B | |
+14.49% | 236B | |
+4.58% | 198B | |
-12.47% | 194B | |
-4.46% | 154B | |
-3.51% | 149B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Barclays Adjusts Eli Lilly and Co.'s Price Target to $355 From $333, Keeps Overweight Rating